BridgeBio Pharma (BBIO) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.4
-1.2
-1
-0.79

Details

Expected EPS
-0.793419
Actual EPS
-0.95
Surprise EPS
-0.16
Surprise Percent
+19.73%

Description

BridgeBio Pharma (BBIO) has reported earnings of -0.95 per share for Q3 2025.

0 Comments

Share your thoughts